81% of Poles Support Medical Cannabis, but Only 4% Have Been Offered It by a Doctor

Seven years after legalizing medical cannabis, 81% of Polish adults support it and 84% would try it if recommended, but only 4.2% have received a physician recommendation.

Silczuk, Andrzej et al.·Frontiers in public health·2025·Moderate EvidenceObservational
RTHC-07657ObservationalModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Moderate Evidence
Sample
N=1,113

What This Study Found

81.1% of respondents supported medical cannabis legalization and 84.3% expressed willingness to undergo treatment if medically indicated. However, only 4.2% reported receiving a physician recommendation. Confidence in physician knowledge (29.9%) and patient knowledge (16.1%) was low. Chronic pain (49.8%) and oncological conditions (57.4%) were the most recognized indications.

Key Numbers

1,113 adults surveyed. 81.1% support legalization. 84.3% willing to try if recommended. 4.2% received physician recommendation. 29.9% confident in physician knowledge. 16.1% confident in patient knowledge. 57.4% recognized oncology indications. 49.8% recognized chronic pain.

How They Did This

Cross-sectional survey conducted July 2025 using computer-assisted web interviewing on a nationally representative sample of 1,113 Polish adults aged 18-84. Multivariable logistic regression identified sociodemographic predictors of key attitudes.

Why This Research Matters

Poland's experience illustrates a common pattern: legalizing medical cannabis does not automatically translate to clinical adoption. The gap between public willingness and physician recommendation highlights systemic barriers in medical education and practice guidelines.

The Bigger Picture

This pattern of high public support but low clinical implementation is seen across many countries that have legalized medical cannabis. Education for healthcare providers and evidence-based clinical guidelines appear to be the primary bottlenecks.

What This Study Doesn't Tell Us

Online survey may underrepresent older adults and rural populations despite nationally representative sampling. Self-reported attitudes may not reflect behavior. Cross-sectional design captures one timepoint. Social desirability bias possible on sensitive topics.

Questions This Raises

  • ?What specific barriers prevent Polish physicians from recommending medical cannabis?
  • ?Would physician education programs increase recommendation rates?

Trust & Context

Key Stat:
Evidence Grade:
Nationally representative survey with validated methodology, but cross-sectional design and self-report limitations place evidence at moderate.
Study Age:
Survey conducted July 2025, seven years after Polish legalization.
Original Title:
Public understanding of medical cannabis in Poland 7 years after legalization: findings from a cross-sectional study.
Published In:
Frontiers in public health, 13, 1686709 (2025)
Database ID:
RTHC-07657

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Why don't more Polish doctors recommend medical cannabis?

The study found low confidence in both physician and patient knowledge about medical cannabis, suggesting education gaps are a major barrier. Only 29.9% of respondents believed doctors are well-informed.

What conditions do people think medical cannabis helps with?

The most commonly recognized indications were cancer-related conditions (57.4%) and chronic pain (49.8%).

Read More on RethinkTHC

Cite This Study

RTHC-07657·https://rethinkthc.com/research/RTHC-07657

APA

Silczuk, Andrzej; Jankowski, Mateusz; Mularczyk-Tomczewska, Paulina; Olearczyk, Agata; Baran, Tomasz; Wrześniewska-Wal, Iwona; Lewandowska, Aleksandra; Łoś, Magdalena. (2025). Public understanding of medical cannabis in Poland 7 years after legalization: findings from a cross-sectional study.. Frontiers in public health, 13, 1686709. https://doi.org/10.3389/fpubh.2025.1686709

MLA

Silczuk, Andrzej, et al. "Public understanding of medical cannabis in Poland 7 years after legalization: findings from a cross-sectional study.." Frontiers in public health, 2025. https://doi.org/10.3389/fpubh.2025.1686709

RethinkTHC

RethinkTHC Research Database. "Public understanding of medical cannabis in Poland 7 years a..." RTHC-07657. Retrieved from https://rethinkthc.com/research/silczuk-2025-public-understanding-of-medical

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.